Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials
Paolo Reboldi(University of Perugia), Verdecchia(Ospedale Santa Maria), Giorgio Gentile(University of Perugia), Fabio Angeli(University of Insubria)
Cited by 51
Related Papers
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
|European Journal of Internal Medicine|2020|1.3k
Adverse Prognostic Significance of New Diabetes in Treated Hypertensive Subjects
|Hypertension|2004|506
Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial
|The Lancet|2009|436
Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention
|Hypertension|2005|339
Short- and Long-Term Incidence of Stroke in White-Coat Hypertension
|Hypertension|2005|318